FDA 483 - Chugai Pharma Manufacturing Co. Ltd. - April 02, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Chugai Pharma Manufacturing Co. Ltd. in Utsunomiya, Japan, a sterile drug manufacturer, revealed a significant deficiency in their aseptic processing. The firm's procedures for preventing microbial contamination of sterile drug products lacked adequate validation of the aseptic process, specifically concerning a smoke study that did not accurately simulate actual processing conditions. This issue impacts numerous vials of finished drug product released for commercial distribution in the U.S.
ID · 4d34740b-5987-4cee-8d49-ef929ff773fd